ENCEFALOPATÍA ESPONGIFORME BOVINA Y SU DIAGNÓSTICO: REVISIÓN Artículo de revisión
Barra lateral del artículo
Publicado:
sep 6, 2015
Palabras clave:
Encefalopatía Espongiforme Bovina (EEB); diagnóstico; Inmunoquímica; Inmunohistoquímica; Bovine Spongiform Encephalopathy (BSE); diagnosis; Immunochemistry; Immunohistochemistry
Contenido principal del artículo
Resumen
Se presentan de forma sistemática los principales métodos de diagnóstico clínico y de laboratorio de la encefalopatía espongiforme bovina (EEB), enfermedad priónica del ganado y otras especies, potencialmente transmisible al ser humano y de alta letalidad. Se incluyen elementos históricos, especies con potencial de infección y transmisión en el contexto de los programas de detección y regulación en el Ecuador.
Descargas
La descarga de datos todavía no está disponible.
Detalles del artículo
Cómo citar
1.
Gabriel B. Pinto, Jorge Espinoza, Selene Juliá, Javier Blanco Viera, Pedro M. Aponte. ENCEFALOPATÍA ESPONGIFORME BOVINA Y SU DIAGNÓSTICO: REVISIÓN. EEC [Internet]. 6 de septiembre de 2015 [citado 27 de abril de 2024];2(2). Disponible en: https://revistaecuadorescalidad.agrocalidad.gob.ec/revistaecuadorescalidad/index.php/revista/article/view/45
Sección
Artículos Científicos
Citas
H.G. Creutzfeldt, (1920)“Uber eine eigenartige herdformige Erkrankung des entralnervensystems”. Z. Gesamte Neurol Psychiatrie 57: 1-18.
A. Jakob, (1921). “Uber eignartige Erkrankungen des Zentralnervensystems mit bemerkenswertem
anatomischen Befunde (spastische Pseudoskleros Encephalomyelopathie mit disseminierten
Degenerationsherden)”. Z. Gesamte Neurol Psychiatrie 64: 147-228.
I. Klatzo; D.C. Gajdusek and V. Zigas, (1959). “Pathology of kuru”. Lab Invest 8: 799-847.
R. G. Will, J. W. Ironside, M. Zeidler, S.N. Cousens, K. Estibeiro, S. Alperovitch, S. Poser, M. Pocchiari, A. Hofman, P.G. Smith, (1996). “A new variant of Crewtzfeld-Jakob disease in the UK”. Lancet 347: 921-925.
R. Chongsuk,(2007). “Prions and Prion Diseases: Fundamentals and Mechanistic Details”. J Microbiol Biotechnol 17: 1059-1070.
GAH Wells and JW Wilesmith(2004). “Bovine spongiform encephalopathy and related diseases”, pp 595-628. In S.B. Prusiner (ed.), Prion Biology and Diseases, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
SB Prusiner, (1982). “Novel proteinaceous infectious particles cause scrapie”. Science 216:136-144.
A Asante, M Smidak, A Grimshaw, R Houghton, A Tomlinson, A Jeelani,T Jakubcova, S Hamdan, A Richard-Londt, JM Linehan , S Brandner, M Alpers, J Whitfield, S Mead, JDF Wadsworth, J Collinge (2015) A naturally occurring variant of the human prion protein completely prevents prion disease. Nature 522:478–481
NA Mabbott (2015) Prospects for safe and effective vaccines against prion diseases. Expert Rev Vaccines 14:1–4
A Trovato, S Panelli, F Strozzi , C Cambulli, I Barbieri, N Martinelli, G Lombardi, R Capoferri, JL
Williams (2015) Expression of genes involved in the T cell signalling pathway in circulating immune cells of cattle 24 months following oral challenge with Bovine Amyloidotic Spongiform Encephalopathy (BASE). BMC Vet Res 11:105
PJ Skinner, HO Kim, D Bryant, NJ Kinzel, C Reilly, SA Priola, AE Ward, PA Goodman, K Olson, DM Seelig (2015) Treatment of Prion Disease with Heterologous Prion Proteins. PloS One 10:e0131993
NJ Cobb and WK Surewicz.(2009). “Prion Diseases and Their Biochemical Mechanisms”. Biochemistry 48: 2574-2585.
MG Doherr, (2007). “Brief review on the epidemiology of transmisible spongiform
encephalopathies (TSE)”. Vaccine 25: 5619 – 5624.
M Scott, D Peretz, RM Ridley, HF Baker, SJ DeArmond, SB Prusiner. (2004). “Transgenetic
investigations of the species barrier and prion strains”, pp.435-482. In S.B. Prusiner (ed), Prion Biology and Diseases, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
V Béringue, J-L Vilotte, H Laude. (2008). “Prion agent diversity and species barrier”. Vet Res 39:47.
H Okada, K Masujin, K Miyazawa, T Yokoyama (2015) Acquired transmissibility of sheep-passaged L-type bovine spongiform encephalopathy prion to wild-type mice. Vet Res 46:81
T Konold, R Nonno, J Spiropoulos, MJ Chaplin, MJ Stack, SAC Hawkins, S Cawthraw, JW Wilesmith, GAH Wells, U Agrimi, MA Di Bari, O Andréoletti, JC Espinosa, P Aguilar-Calvo, JM Torres (2015) Further characterization of transmissible spongiform encephalopathy phenotypes after inoculation of cattle with two temporally separated sources of sheep scrapie from Great Britain. BMC Res Notes 8:312
KA Davenport, DM Henderson, CK Mathiason, EA Hoover (2015) Insights into CWD and BSE species barriers using real-time conversion. J Virol (pii: JVI.01439-15.publicación electrónica antes de
impresión)
SF Godsave, PJ Peters, H Wille (2015) Subcellular distribution of the prion protein in sickness and in health. Virus Res (2015.02.004 publicación electrónica antes de impresión)
E Holznagel, B Yutzy, C Kruip, P Bierke, W Schulz-Schaeffer, J Löwer (2015) Foodborne-Transmitted Prions From the Brain of Cows With Bovine Spongiform Encephalopathy Ascend in
Afferent Neurons to the Simian Central Nervous System and Spread to Tonsils and Spleen at a Late Stage of the Incubation Period. J Infect Dis (publicación electrónica antes de impresión)
DM Henderson, KA Davenport, NJ Haley, ND Denkers, CK Mathiason, EA Hoover (2015) Quantitative assessment of prion infectivity in tissues and body fluids by real-time quaking-induced conversion. J Gen Virol 96:210–219
SB Prusiner. (1991). “Molecular biology of prion diseases”. Science 216: 136-144.
J Priem, JPM Langeveld, LJM van Keulen, FG van Zijderveld, O Andreoletti, A Bossers (2014) Enhanced virulence of sheep-passaged bovine spongiform encephalopathy agent is revealed by decreased polymorphism barriers in prion protein conversion studies. J Virol 88:2903–2912
GAH Wells, AC Scott, CT Johnson, RF Gunning, RD Hancock, M Jeffrey, M Dawson, R Bradley. (1987). “A novel progressive spongiform encephalopathy in cattle”. Vet Rec 121: 419-420.
C Ducrot, M Arnold, A de Koeijer, D Heim, D Calavas. (2008). “Review on the epidemiology and
dynamics of BSE epidemics”. Vet Res 39: 15.
OIE Código sanitario para los animales terrestres 2014. Capítulo. – Encefalopatía Espongiforme Bovina, Capítulo. – Scrapie. www.oie.int/es/normas-internacionales/codigo-terrestre/acceso-en-linea/
Manual de las Pruebas de Diagnóstico y de las Vacunas para los Animales Terrestres 7ª edición 2012 Volumen 1 Parte 2 CAPÍTULO 2.4.6. ISBN 978-92-9044-884-6
AG Biacabe, JL Laplanche; S Ryder; T Baron. (2004) Distinct molecular phenotypes in bovine prion diseases. EMBO Rep 5:110-114
C Casalone; G Zamuso, P Acutis P. et al (2004) Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 101:3065-3070
M Eloit, K Adjou, M Coulpier, JJ Fontaine, R Hamel, T Lilin, S Messiaen, O Andreoletti, T Baron, A Bencsik, AG Biacabe, V Beringue, H Laude, A Le Dur, JL Vilotte, E Comoy, JP Deslys, J Grassi, S Simon, F Lantier, P Sarradin (2005). “BSE agent signatures in a goat.” Vet Rec. 2005 Apr 16;156(16):523-4.
M Jeffrey, S Martin, L González, J Foster, JP Langeveld, FG van Zijderveld, J Grassi, N Hunter (2006) “Immunohistochemical features of PrP(d) accumulation in natural and experimental goat transmissible spongiform encephalopathies.” J Comp Pathol. 2006 Feb-Apr; 134(2-3):171-81.
M Eloit, K Adjou, M Coulpier, JJ Fontaine, R Hamel, T Lilin et al. (2005). « BSE agent signatures in a goat”. Vet Rec 156: 523-524.
O´Rourke K.I., Bazler T.V., Besser T.E. et al. 2000 Preclinical diagnosis of scrapie by
immunohistochemistry of third eyelid lymphoid tissue. J. Clin Microbiol 38:3254-3259
JC Watts, A Balachandran, D Westaway. (2006). “The expanding universe of prion diseases”. Plos Pathog 2: 26.
F Kubler, B Oesch, A Raeber. (2003). “Diagnosis of prion diseases”. Br Med Bull 66: 267-279.
M Jeffrey and L González. (2007). “Classical sheep transmissible spongiform encephalopathies:
pathogenesis, pathological phenotypes and clinical disease”. Neuropathol Appl Neurobiol 33: 373-394.
Y Murayama, K Masujin, M Imamura, F Ono, H Shibata, M Tobiume, T Yamamura, N Shimozaki, K Terao, Y Yamakawa, T Sata (2014). Ultrasensitive detection of PrP(Sc) in the cerebrospinal fluid and blood of macaques infected with bovine spongiform encephalopathy prion. J Gen Virol 95:2576–2588
N Hunter. (2007). “Scrapie – Uncertainties, biology and molecular approaches”. Biochim Biophys Acta 1772: 619-628.
AN Hamir, JM Miller, MJ Schmerr, MJ Stack, MJ Chaplin, RC Cutlip. (2001). “Diagnosis of preclinical and subclinical scrapie in a naturally infected sheep flock utilizing currently available post mortem diagnostic techniques”. J Vet Diagn Invest 13: 152-154.
H B Parry, (1962). “Scrapie: A Transmissible and Heredity Disease Of Sheep”. Heredity, 17: 75-105
SL Benestad, P Sarradin, B Thu, J Schönheit, MA Tranulis, B Bratberg. (2003). “Cases of scrapie with unusual features in Norway and designation of a new type, Nor98”. Vet Rec 153: 202-208.
John Wilesmith, (1988)“Bovine spongiform encephalopathy”. Vet Rec.;122(25):614.
JK Kirkwood, AA Cunningham. (1994)“Epidemiological observations on spongiform
encephalopathies in captive wild animals in the British Isles”. Vet Rec. 135(13):296-303.
JM Wyatt, GR Pearson, TN Smerdon, TJ Gruffydd-Jones, GA Wells, JW Wilesmith.
(1991)“Naturally occurring scrapie-like spongiform encephalopathy in five domestic cats”. Vet
Rec.;129(11):233-6.
GR Hartsough, D Burger.(1965) “Encephalopathy of mink. I. Epizootiologic and clinical observations”.J Infect Dis.;115(4):387-92
ES Williams, S Young. (1982)“Spongiform encephalopathy of Rocky Mountain elk”. J Wildl
Dis.18(4):465-71.
DC Gajdusek and V Zigas. (1957)“Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population”.N Engl J Med.;257(20):974-8
AF Hill, M Desbruslais, S Joiner, KC Sidle, I Gowland, J Collinge, LJ Doey, P Lantos. (1997)“The
same prion strain causes vCJD and BSE.” Nature.389(6650):448-50
J Collinge, KC Sidle, J Meads, J Ironside, AF Hill. (1996)“Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD”. Nature. 383(6602):685-90.
J Gerstmann, E Sträussler, I Scheinker. (1936)“Uber eine eigenartige hereditär-familiäre
Erkrankung des Zetralnervensystems. Zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns”. Z. ges. Neurol Psychiat; 154:736–762
E Lugaresi, R Medori, P Montagna, A Baruzzi, P Cortelli, A Lugaresi, P Tinuper, M Zucconi, P Gambetti. (1986)“Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei”. N Engl J Med, 315:997-1003
A. Jakob, (1921). “Uber eignartige Erkrankungen des Zentralnervensystems mit bemerkenswertem
anatomischen Befunde (spastische Pseudoskleros Encephalomyelopathie mit disseminierten
Degenerationsherden)”. Z. Gesamte Neurol Psychiatrie 64: 147-228.
I. Klatzo; D.C. Gajdusek and V. Zigas, (1959). “Pathology of kuru”. Lab Invest 8: 799-847.
R. G. Will, J. W. Ironside, M. Zeidler, S.N. Cousens, K. Estibeiro, S. Alperovitch, S. Poser, M. Pocchiari, A. Hofman, P.G. Smith, (1996). “A new variant of Crewtzfeld-Jakob disease in the UK”. Lancet 347: 921-925.
R. Chongsuk,(2007). “Prions and Prion Diseases: Fundamentals and Mechanistic Details”. J Microbiol Biotechnol 17: 1059-1070.
GAH Wells and JW Wilesmith(2004). “Bovine spongiform encephalopathy and related diseases”, pp 595-628. In S.B. Prusiner (ed.), Prion Biology and Diseases, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
SB Prusiner, (1982). “Novel proteinaceous infectious particles cause scrapie”. Science 216:136-144.
A Asante, M Smidak, A Grimshaw, R Houghton, A Tomlinson, A Jeelani,T Jakubcova, S Hamdan, A Richard-Londt, JM Linehan , S Brandner, M Alpers, J Whitfield, S Mead, JDF Wadsworth, J Collinge (2015) A naturally occurring variant of the human prion protein completely prevents prion disease. Nature 522:478–481
NA Mabbott (2015) Prospects for safe and effective vaccines against prion diseases. Expert Rev Vaccines 14:1–4
A Trovato, S Panelli, F Strozzi , C Cambulli, I Barbieri, N Martinelli, G Lombardi, R Capoferri, JL
Williams (2015) Expression of genes involved in the T cell signalling pathway in circulating immune cells of cattle 24 months following oral challenge with Bovine Amyloidotic Spongiform Encephalopathy (BASE). BMC Vet Res 11:105
PJ Skinner, HO Kim, D Bryant, NJ Kinzel, C Reilly, SA Priola, AE Ward, PA Goodman, K Olson, DM Seelig (2015) Treatment of Prion Disease with Heterologous Prion Proteins. PloS One 10:e0131993
NJ Cobb and WK Surewicz.(2009). “Prion Diseases and Their Biochemical Mechanisms”. Biochemistry 48: 2574-2585.
MG Doherr, (2007). “Brief review on the epidemiology of transmisible spongiform
encephalopathies (TSE)”. Vaccine 25: 5619 – 5624.
M Scott, D Peretz, RM Ridley, HF Baker, SJ DeArmond, SB Prusiner. (2004). “Transgenetic
investigations of the species barrier and prion strains”, pp.435-482. In S.B. Prusiner (ed), Prion Biology and Diseases, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
V Béringue, J-L Vilotte, H Laude. (2008). “Prion agent diversity and species barrier”. Vet Res 39:47.
H Okada, K Masujin, K Miyazawa, T Yokoyama (2015) Acquired transmissibility of sheep-passaged L-type bovine spongiform encephalopathy prion to wild-type mice. Vet Res 46:81
T Konold, R Nonno, J Spiropoulos, MJ Chaplin, MJ Stack, SAC Hawkins, S Cawthraw, JW Wilesmith, GAH Wells, U Agrimi, MA Di Bari, O Andréoletti, JC Espinosa, P Aguilar-Calvo, JM Torres (2015) Further characterization of transmissible spongiform encephalopathy phenotypes after inoculation of cattle with two temporally separated sources of sheep scrapie from Great Britain. BMC Res Notes 8:312
KA Davenport, DM Henderson, CK Mathiason, EA Hoover (2015) Insights into CWD and BSE species barriers using real-time conversion. J Virol (pii: JVI.01439-15.publicación electrónica antes de
impresión)
SF Godsave, PJ Peters, H Wille (2015) Subcellular distribution of the prion protein in sickness and in health. Virus Res (2015.02.004 publicación electrónica antes de impresión)
E Holznagel, B Yutzy, C Kruip, P Bierke, W Schulz-Schaeffer, J Löwer (2015) Foodborne-Transmitted Prions From the Brain of Cows With Bovine Spongiform Encephalopathy Ascend in
Afferent Neurons to the Simian Central Nervous System and Spread to Tonsils and Spleen at a Late Stage of the Incubation Period. J Infect Dis (publicación electrónica antes de impresión)
DM Henderson, KA Davenport, NJ Haley, ND Denkers, CK Mathiason, EA Hoover (2015) Quantitative assessment of prion infectivity in tissues and body fluids by real-time quaking-induced conversion. J Gen Virol 96:210–219
SB Prusiner. (1991). “Molecular biology of prion diseases”. Science 216: 136-144.
J Priem, JPM Langeveld, LJM van Keulen, FG van Zijderveld, O Andreoletti, A Bossers (2014) Enhanced virulence of sheep-passaged bovine spongiform encephalopathy agent is revealed by decreased polymorphism barriers in prion protein conversion studies. J Virol 88:2903–2912
GAH Wells, AC Scott, CT Johnson, RF Gunning, RD Hancock, M Jeffrey, M Dawson, R Bradley. (1987). “A novel progressive spongiform encephalopathy in cattle”. Vet Rec 121: 419-420.
C Ducrot, M Arnold, A de Koeijer, D Heim, D Calavas. (2008). “Review on the epidemiology and
dynamics of BSE epidemics”. Vet Res 39: 15.
OIE Código sanitario para los animales terrestres 2014. Capítulo. – Encefalopatía Espongiforme Bovina, Capítulo. – Scrapie. www.oie.int/es/normas-internacionales/codigo-terrestre/acceso-en-linea/
Manual de las Pruebas de Diagnóstico y de las Vacunas para los Animales Terrestres 7ª edición 2012 Volumen 1 Parte 2 CAPÍTULO 2.4.6. ISBN 978-92-9044-884-6
AG Biacabe, JL Laplanche; S Ryder; T Baron. (2004) Distinct molecular phenotypes in bovine prion diseases. EMBO Rep 5:110-114
C Casalone; G Zamuso, P Acutis P. et al (2004) Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 101:3065-3070
M Eloit, K Adjou, M Coulpier, JJ Fontaine, R Hamel, T Lilin, S Messiaen, O Andreoletti, T Baron, A Bencsik, AG Biacabe, V Beringue, H Laude, A Le Dur, JL Vilotte, E Comoy, JP Deslys, J Grassi, S Simon, F Lantier, P Sarradin (2005). “BSE agent signatures in a goat.” Vet Rec. 2005 Apr 16;156(16):523-4.
M Jeffrey, S Martin, L González, J Foster, JP Langeveld, FG van Zijderveld, J Grassi, N Hunter (2006) “Immunohistochemical features of PrP(d) accumulation in natural and experimental goat transmissible spongiform encephalopathies.” J Comp Pathol. 2006 Feb-Apr; 134(2-3):171-81.
M Eloit, K Adjou, M Coulpier, JJ Fontaine, R Hamel, T Lilin et al. (2005). « BSE agent signatures in a goat”. Vet Rec 156: 523-524.
O´Rourke K.I., Bazler T.V., Besser T.E. et al. 2000 Preclinical diagnosis of scrapie by
immunohistochemistry of third eyelid lymphoid tissue. J. Clin Microbiol 38:3254-3259
JC Watts, A Balachandran, D Westaway. (2006). “The expanding universe of prion diseases”. Plos Pathog 2: 26.
F Kubler, B Oesch, A Raeber. (2003). “Diagnosis of prion diseases”. Br Med Bull 66: 267-279.
M Jeffrey and L González. (2007). “Classical sheep transmissible spongiform encephalopathies:
pathogenesis, pathological phenotypes and clinical disease”. Neuropathol Appl Neurobiol 33: 373-394.
Y Murayama, K Masujin, M Imamura, F Ono, H Shibata, M Tobiume, T Yamamura, N Shimozaki, K Terao, Y Yamakawa, T Sata (2014). Ultrasensitive detection of PrP(Sc) in the cerebrospinal fluid and blood of macaques infected with bovine spongiform encephalopathy prion. J Gen Virol 95:2576–2588
N Hunter. (2007). “Scrapie – Uncertainties, biology and molecular approaches”. Biochim Biophys Acta 1772: 619-628.
AN Hamir, JM Miller, MJ Schmerr, MJ Stack, MJ Chaplin, RC Cutlip. (2001). “Diagnosis of preclinical and subclinical scrapie in a naturally infected sheep flock utilizing currently available post mortem diagnostic techniques”. J Vet Diagn Invest 13: 152-154.
H B Parry, (1962). “Scrapie: A Transmissible and Heredity Disease Of Sheep”. Heredity, 17: 75-105
SL Benestad, P Sarradin, B Thu, J Schönheit, MA Tranulis, B Bratberg. (2003). “Cases of scrapie with unusual features in Norway and designation of a new type, Nor98”. Vet Rec 153: 202-208.
John Wilesmith, (1988)“Bovine spongiform encephalopathy”. Vet Rec.;122(25):614.
JK Kirkwood, AA Cunningham. (1994)“Epidemiological observations on spongiform
encephalopathies in captive wild animals in the British Isles”. Vet Rec. 135(13):296-303.
JM Wyatt, GR Pearson, TN Smerdon, TJ Gruffydd-Jones, GA Wells, JW Wilesmith.
(1991)“Naturally occurring scrapie-like spongiform encephalopathy in five domestic cats”. Vet
Rec.;129(11):233-6.
GR Hartsough, D Burger.(1965) “Encephalopathy of mink. I. Epizootiologic and clinical observations”.J Infect Dis.;115(4):387-92
ES Williams, S Young. (1982)“Spongiform encephalopathy of Rocky Mountain elk”. J Wildl
Dis.18(4):465-71.
DC Gajdusek and V Zigas. (1957)“Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population”.N Engl J Med.;257(20):974-8
AF Hill, M Desbruslais, S Joiner, KC Sidle, I Gowland, J Collinge, LJ Doey, P Lantos. (1997)“The
same prion strain causes vCJD and BSE.” Nature.389(6650):448-50
J Collinge, KC Sidle, J Meads, J Ironside, AF Hill. (1996)“Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD”. Nature. 383(6602):685-90.
J Gerstmann, E Sträussler, I Scheinker. (1936)“Uber eine eigenartige hereditär-familiäre
Erkrankung des Zetralnervensystems. Zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns”. Z. ges. Neurol Psychiat; 154:736–762
E Lugaresi, R Medori, P Montagna, A Baruzzi, P Cortelli, A Lugaresi, P Tinuper, M Zucconi, P Gambetti. (1986)“Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei”. N Engl J Med, 315:997-1003